Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis

MEASURE 1 and MEASURE 2 Study Groups

Research output: Contribution to journalArticlepeer-review

477 Scopus citations

Fingerprint Dive into the research topics of 'Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis'. Together they form a unique fingerprint.

Medicine & Life Sciences